Experimental conversion of liver to pancreas

Current Biology

Volumn 13, Issue 2, 2003, Pages 105-115

  Horb, Marko E ^a   Shen, Chia Ning ^a   Tosh, David ^a   Slack, Jonathan M W ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; PREALBUMIN; RECOMBINANT DNA; TRANSACTIVATOR PROTEIN; XENOPUS PROTEIN; XLHBOX 8 PROTEIN, XENOPUS;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PANCREAS; PROMOTER REGION; TRANSGENIC ANIMAL; XENOPUS LAEVIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; DIABETES MELLITUS, TYPE 1; DNA, RECOMBINANT; GENE EXPRESSION; HERPES SIMPLEX VIRUS PROTEIN VMW65; HOMEODOMAIN PROTEINS; HUMANS; LIVER; MICE; PANCREAS; PREALBUMIN; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; XENOPUS LAEVIS; XENOPUS PROTEINS;

ANIMALIA; EUKARYOTA; VERTEBRATA; XENOPUS LAEVIS;

EID: 0037458120     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)01434-3     Document Type: Article

References (69)

1. Zimmet, P., Alberti, K.G.M.M., and Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature 414, 782-787.
2. Turner, R.C., Cull, C.A., Frighi, V., and Holman, R.R. (1999). Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281, 2005-2012.
3. Kendall, W.F., Jr., Collins, B.H., and Opara, E.C. (2001). Islet cell transplantation for the treatment of diabetes mellitus. Expert Opin. Biol. Ther. 1, 109-119.
4. Tosh, D., and Slack, J.M.W. (2002). How cells change their phenotype. Nat. Rev. Mol. Cell Biol. 3, 187-194.
5. Slack, J.M.W., and Tosh, D. (2001). Transdifferentiation and metaplasia-switching cell types. Curr. Opin. Genet. Dev. 11, 581-586.
6. Eguchi, G., and Kodama, R. (1993). Transdifferentiation. Curr. Opin. Cell Biol. 5, 1023-1028.
7. Okada, T.S. (1991). Transdifferentiation: Flexibility in Cell Differentiation (Oxford: Clarendon Press).
8. Jankowski, J.A., Wright, N.A., Meltzer, S.J., Triadafilopoulos, G., Geboes, K., Casson, A.G., Kerr, D., and Young, L.S. (1999). Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Pathol. 154, 965-973.
9. Rao, M.S., and Reddy, J.K. (1995). Hepatic transdifferentiation in the pancreas. Semin. Cell Biol. 6, 151-156.
10. Rao, M.S., Dwivedi, R.S., Subbarao, V., Usman, M.I., Scarpelli, D.G., Nemali, M.R., Yeldandi, A., Thangada, S., Kumar, S., and Reddy, J.K. (1988). Almost total conversion of pancreas to liver in the adult rat: a reliable model to study transdifferentiation. Biochem. Biophys. Res. Commun. 156, 131-136.
11. Rao, M.S., Subbarao, V., and Reddy, J.K. (1986). Induction of hepatocytes in the pancreas of copper-depleted rats following copper repletion. Cell Differ. 18, 109-117.
12. Shen, C.N., Slack, J.M.W., and Tosh, D. (2000). Molecular basis of transdifferentiation of pancreas to liver. Nat. Cell Biol. 2, 879-887.
13. Rao, M.S., Bendayan, M., Kimbrough, R.D., and Reddy, J.K. (1986). Characterization of pancreatic-type tissue in the liver of rat induced by polychlorinated biphenyls. J. Histochem. Cytochem. 34, 197-201.
14. Lee, B.C., Hendricks, J.D., and Bailey, G.S. (1989). Metaplastic pancreatic cells in liver tumors induced by diethylnitrosamine. Exp. Mol. Pathol. 50, 104-113.
15. Wolf, H.K., Burchette, J.L., Jr., Garcia, J.A., and Michalopoulos, G. (1990). Exocrine pancreatic tissue in human liver: a metaplastic process? Am. J. Surg. Pathol. 14, 590-595.
16. Wells, J.M., and Melton, D.A. (1999). Vertebrate endoderm development. Annu. Rev. Cell Dev. Biol. 15, 393-410.
17. Deutsch, G., Jung, J., Zheng, M., Lora, J., and Zaret, K.S. (2001). A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128, 871-881.
18. Jung, J., Zheng, M., Goldfarb, M., and Zaret, K.S. (1999). Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284, 1998-2003.
19. Kim, S.K., and Hebrok, M. (2001). Intercellular signals regulating pancreas development and function. Genes Dev. 15, 111-127.
20. Dohrmann, C., Gruss, P., and Lemaire, L. (2000). Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. Mech. Dev. 92, 47-54.
21. Edlund, H. (1998). Transcribing pancreas. Diabetes 47, 1817-1823.
22. McKinnon, C.M., and Docherty, K. (2001). Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 44, 1203-1214.
23. Jonsson, J., Carlsson, L., Edlund, T., and Edlund, H. (1994). Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606-609.
24. Offield, M.F., Jetton, T.L., Labosky, P.A., Ray, M., Stein, R.W., Magnuson, M.A., Hogan, B.L., and Wright, C.V. (1996). PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983-995.
25. Stoffers, D.A., Zinkin, N.T., Stanojevic, V., Clarke, W.L., and Habener, J.F. (1997). Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15, 106-110.
26. Ferber, S., Halkin, A., Cohen, H., Ber, I., Einav, Y., Goldberg, I., Barshack, I., Seijffers, R., Kopolovic, J., Kaiser, N., et al. (2000). Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6, 568-572.
27. Grapin-Botton, A., Majithia, A.R., and Melton, D.A. (2001). Key events of pancreas formation are triggered in gut endoderm by ectopic expression of pancreatic regulatory genes. Genes Dev. 15, 444-454.
28. Heller, R.S., Stoffers, D.A., Hussain, M.A., Miller, C.P., and Habener, J.F. (1998). Misexpression of the pancreatic homeodomain protein IDX-1 by the Hoxa-4 promoter associated with agenesis of the cecum. Gastroenterology 115, 381-387.
29. Kessler, D.S. (1997). Siamois is required for formation of Spemann's organizer. Proc. Natl. Acad. Sci. USA 94, 13017-13022.
30. Sadowski, I., Ma, J., Triezenberg, S., and Ptashne, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
31. Triezenberg, S.J., Kingsbury, R.C., and McKnight, S.L. (1988). Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2, 718-729.
32. Wright, C.V., Schnegelsberg, P., and De Robertis, E.M. (1989). XlHbox 8: a novel Xenopus homeo protein restricted to a narrow band of endoderm. Development 105, 787-794.
33. Kroll, K.L., and Amaya, E. (1996). Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. Development 122, 3173-3183.
34. Yan, C., Costa, R.H., Darnell, J.E., Jr., Chen, J.D., and Van Dyke, T.A. (1990). Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9, 869-878.
35. Beck, C.W., and Slack, J.M.W. (1999). Gut specific expression using mammalian promoters in transgenic Xenopus laevis. Mech. Dev. 88, 221-227.
36. Kruse, F., Rose, S.D., Swift, G.H., Hammer, R.E., and MacDonald, R.J. (1993). An endocrine-specific element is an integral component of an exocrine-specific pancreatic enhancer. Genes Dev. 7, 774-786.
37. Horb, M.E., and Slack, J.M.W. (2002). Expression of amlyase and other pancreatic genes in Xenopus. Mech. Dev. 113, 153-157.
38. Kelly, O.G., and Melton, D.A. (2000). Development of the pancreas in Xenopus laevis. Dev. Dyn. 218, 615-627.
39. Maake, C., Hanke, W., and Reinecke, M. (1998). An immunohistochemical and morphometric analysis of insulin, insulin-like growth factor I, glucagon, somatostatin, and PP in the development of the gastro-entero-pancreatic system of Xenopus laevis. Gen. Comp. Endocrinol. 110, 182-195.
40. Slack, J.M.W. (1995). Developmental biology of the pancreas. Development 121, 1569-1580.
41. Mann, R.S., and Chan, S.K. (1996). Extra specificity from extradenticle:the partnership between HOX and PBX/EXD homeodomain proteins. Trends Genet. 12, 258-262.
42. Mann, R.S., and Affolter, M. (1998). Hox proteins meet more partners. Curr. Opin. Genet. Dev. 8, 423-429.
43. Swift, G.H., Liu, Y., Rose, S.D., Bischof, L.J., Steefman, S., Buchberg, A.M., Wright, C.V., and MacDonald, R.J. (1998). An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2). Mol. Cell. Biol. 18, 5109-5120.
44. Dutta, S., Gannon, M., Peers, B., Wright, C., Bonner-Weir, S., and Montminy, M. (2001). PDX:PBX complexes are required for normal proliferation of pancreatic cells during development. Proc. Natl. Acad. Sci. USA 98, 1065-1070.
45. Goudet, G., Delhalle, S., Biemar, F., Martial, J.A., and Peers, B. (1999). Functional and cooperative interactions between the homeodomain PDX1, Pbx, and Prep1 factors on the somatostatin promoter. J. Biol. Chem. 274, 4067-4073.
46. Liu, Y., MacDonald, R.J., and Swift, G.H. (2001). DNA binding and transcriptional activation by a PDX1.PBX1b.MEIS2b trimer and cooperation with a pancreas-specific basic helix-loop-helix complex. J. Biol. Chem. 276, 17985-17993.
47. Peers, B., Sharma, S., Johnson, T., Kamps, M., and Montminy, M. (1995). The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol. Cell. Biol. 15, 7091-7097.
48. Peshavaria, M., Henderson, E., Sharma, A., Wright, C.V., and Stein, R. (1997). Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol. Cell. Biol. 17, 3987-3996.
49. Prapunpoj, P., Yamauchi, K., Nishiyama, N., Richardson, S.J., and Schreiber, G. (2000). Evolution of structure, ontogeny of gene expression, and function of Xenopus laevis transthyretin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R2026-R2041.
50. Zorn, A.M., and Mason, J. (2001). Gene expression in the embryonic Xenopus liver. Mech. Dev. 103, 153-157.
51. Newman, C.S., Chia, F., and Krieg, P.A. (1997). The XHex homeobox gene is expressed during development of the vascular endothelium: overexpression leads to an increase in vascular endothelial cell number. Mech. Dev. 66, 83-93.
52. Kawahara, A., Hikosaka, A., Sasado, T., and Hirota, K. (1997). Thyroid hormone-dependent repression of alpha1-microglobulin/bikunin (AMBP) gene expression during amphibian metamorphosis. Dev. Genes Evol. 206, 355-362.
53. Blaner, W.S., Bonifacio, M.J., Feldman, H.D., Piantedosi, R., and Mascarenhas-Saraiva, M.J. (1991). Studies on the synthesis and secretion of transthyretin by the human hepatoma cell line Hep G2. FEBS Lett. 287, 193-196.
54. Knowles, B.B., Howe, C.C., and Aden, D.P. (1980). Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209, 497-499.
55. Yang, L., Li, S., Hatch, H., Ahrens, K., Cornelius, J.G., Petersen, B.E., and Peck, A.B. (2002). In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. USA 99, 8078-8083.
56. Ohlsson, H., Karlsson, K., and Edlund, T. (1993). IPF1, a homeo-domain-containing transactivator of the insulin gene. EMBO J. 12, 4251-4259.
57. Featherstone, M. (2002). Coactivators in transcription initiation: here are your orders. Curr. Opin. Genet. Dev. 12, 149-155.
58. Marcus, G.A., Silverman, N., Berger, S.L., Horiuchi, J., and Guarente, L. (1994). Functional similarity and physical association between GCN5 and ADA2: putative transcriptional adaptors. EMBO J. 13, 4807-4815.
59. Muller, C., and Leutz, A. (2001). Chromatin remodeling in development and differentiation. Curr. Opin. Genet. Dev. 11, 167-174.
60. Mahmoudi, T., and Verrijzer, C.P. (2001). Chromatin silencing and activation by Polycomb and trithorax group proteins. Oncogene 20, 3055-3066.
61. Tumbar, T., Sudlow, G., and Belmont, A.S. (1999). Large-scale chromatin unfolding and remodeling induced by VP16 acidic activation domain. J. Cell Biol. 145, 1341-1354.
62. Tumbar, T., and Belmont, A.S. (2001). Interphase movements of a DNA chromosome region modulated by VP16 transcriptional activator. Nat. Cell Biol. 3, 134-139.
63. Hofmann, F., Martelli, F., Livingston, D.M., and Wang, Z. (1996). The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev. 10, 2949-2959.
64. Hateboer, G., Kerkhoven, R.M., Shvarts, A., Bernards, R., and Beijersbergen, R.L. (1996). Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10, 2960-2970.
65. Salghetti, S.E., Caudy, A.A., Chenoweth, J.G., and Tansey, W.P. (2001). Regulation of transcriptional activation domain function by ubiquitin. Science 293, 1651-1653.
66. Tansey, W.P. (2001). Transcriptional activation: risky business. Genes Dev. 15, 1045-1050.
67. Chi, Y., Huddleston, M.J., Zhang, X., Young, R.A., Annan, R.S., Carr, S.A., and Deshaies, R.J. (2001). Negative regulation of Gcn4 and Msn2 transcription factors by Srb10cyclin-dependent kinase. Genes Dev. 15, 1078-1092.
68. Slack, J.M.W. (2001). Skinny dipping for stem cells. Nat. Cell Biol. 3, E205-E206.
69. Harland, R.M. (1991). In situ hybridization: an improved whole mount method for Xenopus embryos. Meth. Cell Biol. 36, 675-685.